Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 23.35% vs 29.26% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 66.71% vs 35.74% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 29.01% vs 29.02% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 4.80% vs 12.45% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Kwality Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -0.39% vs -3.63% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 23.35% vs 29.26% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 18.36% vs -17.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 66.71% vs 35.74% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 4.88% vs -6.68% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 29.01% vs 29.02% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 2.90% vs 10.84% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 4.80% vs 12.45% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






